Understanding Chemotherapy in Pakistan: Process, Side Effects, and Cost

Understanding Chemotherapy in Pakistan: Process, Side Effects, and Cost

Cancer and blood disorders are conditions that many families in Pakistan face today. Among the available treatment options, chemotherapy remains one of the most widely used approaches for managing both solid tumours and haematological malignancies, including leukaemia, lymphoma and multiple myeloma. Alongside this, haematology plays an important role in diagnosing, managing and treating blood cancers and non-malignant blood disorders.

This article provides a comprehensive overview of oncology⁠ and haematology in Pakistan, focusing on chemotherapy, its treatment process, possible side effects, costs and the importance of specialised medical teams and aftercare.

What Is Chemotherapy in Haematology?

Chemotherapy, commonly referred to as chemo, involves using medicines to destroy cancer cells or slow their growth. In haematology, it is particularly important for treating blood cancers (haematological malignancies) such as:

  • Leukaemia (AML, ALL, CML and CLL)
  • Lymphoma (Hodgkin and non-Hodgkin)
  • Multiple myeloma
  • Myelodysplastic syndromes (MDS)

Chemotherapy may be administered independently or alongside other treatments, including immunotherapy, targeted therapy, radiotherapy or bone marrow transplantation (BMT)⁠.

In Pakistan, chemotherapy services are available at major oncology and haematology centres, including the National Institute of Blood Disease & Bone Marrow Transplantation (NIBD), Aga Khan University Hospital and Shaukat Khanum Memorial Cancer Hospital. These institutions provide specialised services for patients with different types of cancer and blood disorders.

Types of Chemotherapy in Oncology and Haematology

Chemotherapy can be categorised according to its timing and treatment objectives:

  • Neoadjuvant Chemotherapy: Administered before surgery or another definitive treatment to shrink tumours or reduce the disease burden.
  • Adjuvant Chemotherapy: Given after surgery to target cancer cells that may remain and reduce the risk of recurrence.
  • Induction Chemotherapy: Commonly used in blood cancers, particularly leukaemia, to achieve remission by reducing cancer cells.
  • Consolidation and Maintenance Chemotherapy: Used in certain blood cancers to strengthen treatment response, maintain remission and reduce the risk of relapse.
  • Palliative Chemotherapy: Recommended in some advanced cancers to control disease, relieve symptoms and improve quality of life.

The choice of chemotherapy depends on the cancer type, stage, treatment goals and the patient’s overall health.

How Chemotherapy Works in Blood Cancers

Chemotherapy medicines target rapidly dividing cancer cells. However, normal cells in the bone marrow also divide quickly, which means treatment can affect healthy blood cell production. This can lead to side effects such as low blood counts, infections and anaemia, particularly in patients receiving intensive treatment for blood cancers.

Chemotherapy can be administered through different methods, depending on the prescribed medicines and the patient’s condition:

  • Intravenous (IV): Medicines are delivered directly into a vein and are commonly administered in oncology and haematology units.
  • Oral Medications: Certain chemotherapy or other anti-cancer medicines are taken by mouth. For example, imatinib is commonly used to treat chronic myeloid leukaemia (CML).
  • Intrathecal Chemotherapy: Medication is delivered into the cerebrospinal fluid to treat or prevent cancer involvement in the central nervous system in selected cases.

Treatment is often organised into cycles, with planned breaks between sessions to allow the body to recover. The length and frequency of these cycles vary according to the treatment regimen.

Chemotherapy and Haematology Care in Pakistan: The Process

Chemotherapy involves several stages, from confirming the diagnosis to monitoring the patient’s response and managing possible complications.

1. Diagnosis and Staging

Doctors begin by reviewing the patient’s symptoms, medical history and investigation results. Depending on the suspected condition, tests may include a complete blood count (CBC), bone marrow biopsy, flow cytometry, cytogenetic testing, molecular investigations and imaging.

2. Treatment Planning

A multidisciplinary team involving oncologists, haematologists, pathologists and radiologists reviews the findings and determines an appropriate treatment plan. The recommended approach depends on the type of cancer, its characteristics and the patient’s overall health.

3. Pre-Treatment Counselling

Before chemotherapy begins, patients and families receive information about the treatment schedule, possible side effects, precautions and expected monitoring. They may also be advised about nutrition, infection prevention and lifestyle adjustments.

4. Administration of Chemotherapy

Treatment is provided in specialised day-care chemotherapy units or during hospital admission. Some patients can return home after their sessions, while those receiving intensive induction regimens may require closer supervision or hospitalisation.

5. Monitoring and Supportive Care

Regular monitoring of blood counts, infections and organ function is essential, particularly for patients receiving intensive chemotherapy. Supportive medicines and interventions may include growth factors, antibiotics, antifungals and blood transfusions when clinically required.

6. Post-Treatment Support

After chemotherapy, patients continue to attend follow-up appointments to assess treatment response, monitor for relapse and manage ongoing side effects. Some patients may also require further treatment or an assessment for a stem cell or bone marrow transplant.

Common Side Effects of Chemotherapy in Haematological Malignancies

Chemotherapy affects rapidly dividing cells, which can include healthy cells in the digestive system, hair follicles and bone marrow. Common side effects include:

  • Severe fatigue and weakness.
  • Hair loss.
  • Nausea and vomiting.
  • Mouth sores.
  • Infections due to neutropenia (low white blood cell count).
  • Anaemia due to reduced red blood cell production.
  • Increased bleeding or bruising due to low platelet counts.
  • Weight loss and reduced appetite.

The severity of these effects varies depending on the medicines, dosage and individual response to treatment.

Haematology patients may require additional supportive care, including blood transfusions, growth factors such as G-CSF and infection prevention measures. Patients should contact their treatment team promptly if they develop a fever or other signs of infection, as complications can become serious when blood counts are low.

Cost of Chemotherapy and Haematology Treatment in Pakistan

The cost of chemotherapy in Pakistan varies according to the cancer type, disease stage, medicines prescribed, number of treatment cycles and level of supportive care required.

A national cancer-care survey published on 5 September 2026 found that 94.6% of surveyed oncology professionals in Pakistan reported financial barriers to cancer care. The survey included 111 oncology professionals across 10 cities in four provinces.

Indicative estimates sometimes quoted for treatment include:

  • Government hospitals: Approximately PKR 150,000–200,000 for certain standard chemotherapy cycles, depending on the treatment and services included.
  • Private hospitals: Costs may range from PKR 400,000 to PKR 2 million or more, particularly when expensive medicines, targeted therapies or extended hospital care are required.
  • Bone Marrow Transplant (BMT): Estimates may range from PKR 3.5 million to PKR 7 million, depending on the transplant type, hospital and associated care.

These figures should be treated as broad estimates rather than standard prices. Actual expenses can differ considerably, and patients should request an individualised cost breakdown from their hospital.

Centres such as NIBD⁠ may also help patients explore financial assistance options and available support arrangements. Patients should speak with the hospital’s administration or welfare department to understand eligibility and documentation requirements.

Choosing the Right Haematology and Oncology Centre

Selecting an appropriate hospital is an important part of cancer treatment. Patients should consider whether the facility offers the specialist expertise, medical equipment and supportive services required for their condition.

Important features to look for include:

  • Experienced haematologists and oncologists.
  • Multidisciplinary tumour boards for individualised treatment planning.
  • Specialised chemotherapy day-care units.
  • Bone marrow transplant (BMT) facilities, where required.
  • Emergency and intensive care support.
  • Access to targeted therapies and clinical trials, where available.

Some recognised healthcare centres in Pakistan include:

Patients should compare facilities according to their diagnosis, treatment requirements, accessibility and available specialist services.

After-Treatment and Survivorship Support

Recovery for patients receiving treatment for blood cancers often extends beyond the final chemotherapy session. Continued medical supervision and supportive care help monitor progress and address long-term effects.

Important aspects of after-treatment care include:

  • Regular follow-up tests: Blood tests and other investigations help monitor treatment response and identify possible relapse.
  • Nutrition and physical rehabilitation: Nutritionists and physiotherapists can help patients rebuild strength and manage changes in appetite, weight and energy levels.
  • Psychological counselling: Emotional support can help patients and families cope with anxiety, stress and the challenges of recovery.
  • Palliative care: For patients with advanced disease or difficult symptoms, palliative care can help manage discomfort and improve quality of life.

The follow-up schedule is personalised according to the patient’s diagnosis, treatment and recovery needs.

Final Thoughts

Facing cancer or a blood disorder can be overwhelming, but awareness, timely diagnosis and access to specialised haematology and oncology care⁠ can help patients receive appropriate treatment and support.

Chemotherapy in Pakistan continues to develop alongside improvements in medicines, specialist expertise and supportive care. Although treatment costs can be a significant concern, financial assistance programmes and welfare organisations may provide support to eligible families.

If you or a loved one is seeking treatment, consult a qualified haematologist or oncologist at a trusted healthcare centre. Early intervention, regular monitoring and appropriate aftercare remain important throughout the treatment journey. With the right medical guidance and support, patients can better understand their options and make informed decisions about managing both solid tumours and haematological malignancies.

Frequently Asked Questions

1. What is chemotherapy used for in haematology?

Chemotherapy is used to treat several blood cancers, including leukaemia, lymphoma and multiple myeloma. It works by destroying cancer cells or slowing their growth, depending on the prescribed treatment.

2. How is chemotherapy administered in Pakistan?

Chemotherapy may be given intravenously, orally or through other specialised methods, such as intrathecal administration. The method depends on the cancer type, prescribed medicines and patient’s condition.

3. What are the most common side effects of chemotherapy?

Common side effects include fatigue, nausea, vomiting, hair loss, mouth sores, infections, anaemia and low platelet counts. Their severity varies between patients and treatment regimens.

4. How much does chemotherapy cost in Pakistan?

Costs depend on the medicines, number of cycles, hospital and supportive care required. Patients should request a personalised estimate because treatment expenses can vary considerably.

5. How long does a chemotherapy treatment cycle last?

The duration depends on the cancer type and treatment regimen. Some cycles last a few weeks, while complete treatment may involve several cycles over a longer period.

6. What happens after chemotherapy is completed?

Patients usually require regular follow-up appointments, blood tests and other investigations to monitor recovery and treatment response. Some may also need rehabilitation, nutritional guidance or additional treatment.